BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9315068)

  • 1. Current concepts about testicular cancer.
    van Basten JP; Schrafford Koops H; Sleijfer DT; Pras E; van Driel MF; Hoekstra HJ
    Eur J Surg Oncol; 1997 Aug; 23(4):354-60. PubMed ID: 9315068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular cancer.
    Nichols CR
    Curr Probl Cancer; 1998; 22(4):187-274. PubMed ID: 9743088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Late toxicity after chemotherapy of malignant testicular tumors].
    Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
    Urologe A; 1998 Nov; 37(6):635-47. PubMed ID: 9887493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early-stage testis cancer.
    Foster RS
    Curr Treat Options Oncol; 2001 Oct; 2(5):413-9. PubMed ID: 12057104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
    Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
    Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Stage IIA-IIC Seminoma: Radiation Therapy versus Systemic Chemotherapy versus Retroperitoneal Lymph Node Dissection.
    von Amsberg G; Hamilton R; Papachristofilou A
    Oncol Res Treat; 2018; 41(6):360-363. PubMed ID: 29763926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of patients with testicular germ cell cancer.
    Hartmann JT; Kanz L; Bokemeyer C
    Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment in germ cell tumours: state of the art.
    Tjan-Heijnen VC; Oosterhof GO; de Wit R; De Mulder PH
    Eur J Surg Oncol; 1997 Apr; 23(2):110-7. PubMed ID: 9158183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of metastatic seminoma by chemotherapy.: an experience].
    Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
    Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of advanced testicular cancer.
    Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
    JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of stage I testicular germ cell tumours.
    Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
    Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term complications of chemotherapy for germ cell tumours.
    Chaudhary UB; Haldas JR
    Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
    Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
    Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of pure seminoma at post-chemotherapy retroperitoneal lymph node dissection.
    Rice KR; Beck SD; Bihrle R; Cary KC; Einhorn LH; Foster RS
    J Urol; 2014 Nov; 192(5):1397-402. PubMed ID: 24813309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.